Cargando…

Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer

Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype. It disproportionately affects BRCA mutation carriers and young women, especially African American (AA) women. Chemoresistant TNBC is a heterogeneous and molecularly unstable disease that challenges our ability to appl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Amy H., Hoefer, Richard A., Guye, Mary L., Bear, Harry D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511813/ https://www.ncbi.nlm.nih.gov/pubmed/36176751 http://dx.doi.org/10.20517/cdr.2022.31

Ejemplares similares

SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast Cancer
por: van Reesema, Lauren L. Siewertsz, et al.
Publicado: (2016)

Inhibition of Siah2 Ubiquitin Ligase by Vitamin K3 Attenuates Chronic Myeloid Leukemia Chemo-Resistance in Hypoxic Microenvironment
por: Huang, Jixian, et al.
Publicado: (2018)

Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies
por: Gupta, Gagan K., et al.
Publicado: (2020)

Current Approaches in NSCLC Targeting K-RAS and EGFR
por: Aran, Veronica, et al.
Publicado: (2019)

Investigating the Molecular Basis of Siah1 and Siah2 E3 Ubiquitin Ligase Substrate Specificity
por: Gopalsamy, Anupriya, et al.
Publicado: (2014)

The PARP1-Siah1 Axis Controls HIV-1 Transcription and Expression of Siah1 Substrates
por: Yu, Dan, et al.
Publicado: (2018)

The Ubiquitin Ligase SIAH2 Negatively Regulates Glucocorticoid Receptor Activity and Abundance
por: Burke, Susan J., et al.
Publicado: (2020)

Unmet Clinical Need: Developing Prognostic Biomarkers and Precision Medicine to Forecast Early Tumor Relapse, Detect Chemo-Resistance and Improve Overall Survival in High-Risk Breast Cancer
por: Gupta, Gagan, et al.
Publicado: (2020)

Targeting EGFR in Triple Negative Breast Cancer
por: Ueno, Naoto T., et al.
Publicado: (2011)

Mechanism-Based Sonodynamic–Chemo Combinations against Triple-Negative Breast Cancer
por: Feng, Xiaolan, et al.
Publicado: (2022)

Enhanced Therapeutic Efficacy of Combining Losartan and Chemo-Immunotherapy for Triple Negative Breast Cancer
por: Zhao, Qing, et al.
Publicado: (2022)

Phylogenetic analysis of the SINA/SIAH ubiquitin E3 ligase family in Metazoa
por: Pepper, Ian J., et al.
Publicado: (2017)

Cathepsin K promotes the proliferation of hepatocellular carcinoma cells through induction of SIAH1 ubiquitination and degradation
por: Zhang, Chengming, et al.
Publicado: (2023)

HPIP is an essential scaffolding protein running through the EGFR-RAS-ERK pathway and drives tumorigenesis
por: Jiang, Qiwei, et al.
Publicado: (2023)

Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations
por: Secq, V, et al.
Publicado: (2014)

Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance
por: Li, Shenduo, et al.
Publicado: (2015)

Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer
por: Doddapaneni, Ravi, et al.
Publicado: (2017)

Abrogating Metastatic Properties of Triple-Negative Breast Cancer Cells by EGFR and PI3K Dual Inhibitors
por: Garcia, Ana Rita, et al.
Publicado: (2023)

A Drosophila Model for EGFR-Ras and PI3K-Dependent Human Glioma
por: Read, Renee D., et al.
Publicado: (2009)

EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition
por: Rotella, Virginia, et al.
Publicado: (2014)

Characteristics of recurrence, predictors for relapse and prognosis of rapid relapse triple-negative breast cancer
por: Cai, Shuang-Long, et al.
Publicado: (2023)

Fine Tuning of the UPR by the Ubiquitin Ligases Siah1/2
por: Scortegagna, Marzia, et al.
Publicado: (2014)

P-TEFb is degraded by Siah1/2 in quiescent cells
por: Huang, Fang, et al.
Publicado: (2022)

BCATc modulates crosstalk between the PI3K/Akt and the Ras/ERK pathway regulating proliferation in triple negative breast cancer
por: Shafei, Mai Ahmed, et al.
Publicado: (2020)

EGFRAP encodes a new negative regulator of the EGFR acting in both normal and oncogenic EGFR/Ras-driven tissue morphogenesis
por: Soler Beatty, Jennifer, et al.
Publicado: (2021)

EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?
por: Paliga, A, et al.
Publicado: (2012)

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC
por: Kalikaki, A, et al.
Publicado: (2008)

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers
por: Linklater, Erik S., et al.
Publicado: (2016)

Expression and clinical significance of MAPK and EGFR in triple-negative breast cancer
por: Jiang, Weihua, et al.
Publicado: (2020)

K-RAS Associated Gene-Mutation-Based Algorithm for Prediction of Treatment Response of Patients with Subtypes of Breast Cancer and Especially Triple-Negative Cancer
por: Johnson, Heather, et al.
Publicado: (2022)

Spatholobus suberectus inhibits lipogenesis and tumorigenesis in triple-negative breast cancer via activation of AMPK-ACC and K-Ras-ERK signaling pathway
por: Zeng, Xiaohui, et al.
Publicado: (2023)

Phosphorylated EGFR Dimers Are Not Sufficient to Activate Ras
por: Liang, Samantha I., et al.
Publicado: (2018)

Siah1 proteins enhance radiosensitivity of human breast cancer cells
por: He, Hai-Tao, et al.
Publicado: (2010)

Siah2 control of T-regulatory cells limits anti-tumor immunity
por: Scortegagna, Marzia, et al.
Publicado: (2020)

SIAH ubiquitin E3 ligases as modulators of inflammatory gene expression
por: Schmitz, M. Lienhard, et al.
Publicado: (2022)

Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells
por: Yi, Yong Weon, et al.
Publicado: (2013)

Cascade Release Nanocarriers for the Triple-Negative Breast Cancer Near-Infrared Imaging and Photothermal-Chemo Synergistic Therapy
por: Li, Ke, et al.
Publicado: (2021)

Single Atom‐Doped Nanosonosensitizers for Mutually Optimized Sono/Chemo‐Nanodynamic Therapy of Triple Negative Breast Cancer
por: Chen, Qiqing, et al.
Publicado: (2023)

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
por: Van Emburgh, Beth O., et al.
Publicado: (2016)

Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer
por: Guerrab, Abderrahim El, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b91g8j14jvn2lq1pusvu8uk76i